Les Laboratoires Servier has been granted a patent for a compound of formula (I) and its use in manufacturing medicaments. The compound’s specific structure and potential applications are outlined in the claim. GlobalData’s report on Les Laboratoires Servier gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Les Laboratoires Servier, Cancer treatment biomarkers was a key innovation area identified from patents. Les Laboratoires Servier's grant share as of January 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent (Publication Number: US11833162B2) discloses a compound of formula (I) with specific structural features, including the presence of methyl groups, heterocycles, and certain substituents. The compound is further defined by the representation of various groups and atoms, such as hydrogen, halogen, and cyano groups, within the molecule. Additionally, the patent claims specific compounds within the defined structure, highlighting their chemical composition and arrangement.
Moreover, the patent extends to pharmaceutical compositions containing the disclosed compound or its addition salts with pharmaceutically acceptable acids or bases. These compositions are intended for use in combination with anti-cancer agents, including genotoxic agents, mitotic poisons, anti-metabolites, proteasome inhibitors, kinase inhibitors, and antibodies. The combination of the compound with these anti-cancer agents is formulated with pharmaceutically acceptable excipients for potential therapeutic applications in the treatment of cancer.
To know more about GlobalData’s detailed insights on Les Laboratoires Servier, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
